ADAMED is an international laboratory specialized in specialists. With a young and dynamic style, we offer new solutions tailored to the daily needs of specialists. Our global presence is backed by a strong position in R&D, fully committed to innovation, quality, and service, dedicating ourselves to our work with heart and mind.

More information about ADAMED can be found at www.adamed.com/en/main-page.

AliveCor revolutionises heart care with intelligent, personalised heart data for clinicians and patients, available anytime, anywhere. KardiaMobile 6L, the world’s first FDA-cleared six-lead personal ECG, provides accurate readings in 30 seconds, detecting six common arrhythmias. Patients can monitor their heart health at home, sharing real-time data with healthcare providers. AliveCor’s SDK and API solutions enable seamless integration of Kardia technology into clinical platforms. The InstantQT point-of-care solution offers fast QT measurements*, supporting safer use of antipsychotic medications. AliveCor enhances accessibility, fosters trust, and delivers actionable insights to transform global cardiovascular care.

*QT measurements made using the EK12 ECG algorithm from GE

More information about AliveCor can be found at www.alivecor.co.uk.

BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. We are boldly advancing neuroscience with our proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder (OCD), and smoking addiction. We are dedicated to leading through superior science and building on our unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. BrainsWay is dual-listed on the NASDAQ and Tel Aviv Stock Exchange (TASE).

More information about BrainsWay can be found at www.brainsway.com.

Cambridge University Press is a not-for-profit publisher that dates from 1534 and is part of the University of Cambridge. Our mission is to unlock people’s potential with the best learning and research solutions by combining state-of-the-art content with the highest standards of scholarship, writing and production. Visit our stand to discuss publishing with us, browse our latest publications, and access a collection of free chapters and journal articles. We will be offering a discount of 30% off and free shipping on purchases made online for 30 days from the conference start date.

More information about Cambridge University Press can be found at www.cambridge.org/epa2025.

CEREBRUM VR provides cutting-edge, scientifically-driven solutions designed to enhance mental health and well-being. At the heart of our work lies the creation, testing, and development of immersive Virtual Reality technologies tailored for psychiatric rehabilitation, neuropsychological treatments, psychological support, and psychotherapeutic interventions. Our mission is simple: to make therapies more effective and ultimately elevate patients’ quality of life.

More information about CEREBRUM VR can be found at www.cerebrumvr.com.

DEYMED Diagnostic is a leading Czech company with an established global existence, specialising in advanced medical diagnostic and treatment technologies for neurophysiology and psychiatry. Founded in 1997, DEYMED has expanded its product range over the years to include EEG, EMG, TMS (Transcranial Magnetic Stimulation), PSG (Polysomnography), and BFB (Biofeedback) systems, trusted by healthcare providers worldwide for their precision, reliability, and ease of use.

More information about DEYMED Diagnostic can be found at www.deymed.com.

EUFAMI, founded in 1992, is a democratic, international non-profit organisation based in Belgium, committed to improving the care and welfare of people affected by mental ill health. It advocates for the rights of family carers to be recognised as equal partners in care decisions and for equitable mental health services across Europe. EUFAMI supports member associations, promotes best practices, and lobbies policymakers to ensure adequate resources and non-discriminatory policies. Its vision is a society where people with mental ill health and their families are fully included, enjoying the same social, economic, and political rights as others without discrimination.

More information about EUFAMI and be found at www.eufami.org.

The European Academy of Neurology (EAN) is a non-profit, independent organization representing over 45,000 members and 48 national societies across Europe. As Europe’s Home of Neurology, EAN fosters neurological excellence, advances research, and improves patient care. Through 32 Scientific and Coordinating Panels, experts collaborate to promote quality and innovation in neurology. EAN also works to maintain Europe’s position as a global leader in neurological research. Led by renowned neurology experts, who volunteer their time, EAN brings together clinicians, educators, and scientists to shape the future of neurology and ensure continuous progress in the field.

More information about The European Academy of Neurology can be found at www.ean.org.

A non-profit organisation based in Brussels, its main mission is to promote brain research with the ultimate goal of improving the lives of the estimated 179 million Europeans living with brain conditions. With the aim to speak with one voice, EBC stands as the platform to foster cooperation between its member organisations and other stakeholders, consistently promoting dialogue between scientists, industry and society.

More information about European Brain Council can be found at www.braincouncil.eu/.

Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on hyaluronic acid (~1,200 patents) in joint care, skin care, eye care, aesthetic care, specialty care and regenerative care. Manufacturing operations – located in Italy – are inspected and approved by major international health authorities, including the US FDA, and comply with the strictest international regulations and safety standards. Fidia extends its global reach through local partners in +120 countries worldwide, as well as wholly owned subsidiaries in USA, Germany, Austria, Spain, France, Russia, Czech Republic, Slovakia, Romania, Poland, Egypt and Middle East.

More information about Fidia Farmaceutici S.p.a can be found at www.fidiapharma.com.

Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe) is a non-profit, patient-driven pan-European organisation representing and advocating for the interests and rights of people affected by mental illness. Its principal activities include advocacy, information, awareness-raising, education, partnership, and capacity building. Our work’s overarching themes include destigmatising mental illness and championing patients’ rights.

More information about GAMBIAN-Europe can be found at www.gamian.eu.

As a leading provider of point-of-care diagnostic solutions, we enable healthcare practitioners across clinical settings and geographies to improve patient outcomes and clinical workflows.

More information about HemoCue can be found at www.hemocue.com/en/.

Pioneers in Light Therapy In 2006, we were the first to come up with a wearable light therapy device that could be integrated into your morning routine. 4 years of research at the University of Liège in Belgium led to the creation of the first light therapy glasses, combining effectiveness and ease of use. The effectiveness of a light therapy lamp depends on the regularity with which it is used. In practice, it is difficult to sit in front of a light therapy lamp for 30 minutes every day. Thanks to the Luminette, you will be able to do your light therapy session while remaining active and light therapy will not be a constraint. You will therefore have a better chance of feeling the positive effects of light on your energy level and the quality of your sleep.

More information about Lucimed can be found at www.myluminette.com.

MagVenture is a market-leading manufacturer of non-invasive Transcranial Magnetic Stimulation (TMS) and Magnetic Peripheral Nerve Stimulation (mPNS) systems. Privately-owned and headquartered in Denmark, MagVenture has been pioneering cutting-edge magnetic stimulation solutions for more than 30 years. MagVenture’s TMS and mPNS systems are used for a wide range of applications in both research and treatment in the fields of psychiatry, neurophysiology, neurology, cognitive neuroscience, and rehabilitation. MagVenture’s vision is to offer new hope to patients by transforming how mental health and physical conditions are treated. Our mission is to pioneer safe, effective, and reliable magnetic stimulation therapies, offer innovative and versatile research solutions and work to expand access to magnetic stimulation worldwide. MagVenture’s products are available on the global market through direct sales subsidiaries in the USA, Germany, the UK, China, and Brazil, and through a global network of distributors.

More information on MagVenture can be found at www.magventure.com/en_eur/.

MatchMedics is Ireland’s top medical recruitment agency, specializing in Psychiatrists, GPs, and all specialties for doctors seeking new career opportunities. Ireland offers some of the highest Consultant salaries in the EU, ranging from €231,214 to €277,736, with a balanced 37-hour workweek. Enjoy a thriving career while experiencing Ireland’s stunning landscapes, vibrant culture, and world-famous scenery. With roles available nationwide, now is the perfect time to advance your career in a country that values both professional growth and quality of life. Take the next step—make Ireland your destination for success and a fulfilling lifestyle!

More information about MatchMedics can be found at www.matchmedics.com.

At Neurotorium.org, our mission is to improve awareness and knowledge of the brain and its diseases. We provide unbiased and freely available, online educational content created for clinicians, educators and all who are interested in learning more about the brain. All our educational material is developed, reviewed, and regularly updated by leading experts within the fields of psychiatry, neurology, and neuroscience. Neurotorium.org is a non-commercial, non-profit initiative founded by the Lundbeck Foundation.

More information on Neurotorium can be found at www.neurotorium.org.

Saladax Biomedical, Inc. offers rapid, precise therapeutic drug monitoring assays for psychiatric medications, for both clinical laboratories and at the point-of-care. Our MyCare™ Psychiatry assays provide quantitative insights for optimizing patient care. Revolutionizing psychiatric care, the MyCare Insite is a groundbreaking point-of-care device to measure clozapine and total aripiprazole, enabling real-time decision-making during patient consultations.

More information about Saladax Biomedical Inc. can be found at www.mycaretests.com.

Based in Switzerland, STORZ MEDICAL develops innovative shock wave systems for extracorporeal treatment of kidney stones since late 1980s. Today, we employ shock waves in the treatment of musculoskeletal disorders, pseudarthrosis and angina pectoris. In the 1990s, we discovered the effectiveness of shock waves in the treatment of peripheral neurological diseases such as post-traumatic spasms and polyneuropathy. The first treatment of Alzheimer’s patients with shock waves was in 2014. In 2018, Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system was the first of its kind to obtain authorization for the treatment of the central nervous system of Alzheimer’s patients. Resulting from this success, neurological diseases such as Parkinson, stroke and spinal cord injuries are a focus in our development activities.

More information about STORZ MEDICAL AG can be found at www.storzmedical.com

Yingchi Technology is based in Shenzhen, China, specializing in the research and application of advanced technologies for diagnosing and treating brain and neurological diseases. Established in 2012, it is a high-tech enterprise with a strong R&D team dedicated to improving healthcare and patient outcomes. Ionclinics is a leading medical device company focused on non-invasive therapies for neurological conditions. Their team integrates medical and technical expertise to create innovative, user-friendly, and safe products that enhance patients’ quality of life.

More information about YINGCHI – IONCLINICS can be found at www.yingchitech.com/en.